Rationalizing prescribing for oral and oesophageal candidiasis

Int J STD AIDS. 1996 Oct;7(6):452. doi: 10.1258/0956462961918310.
No abstract available

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy*
  • Antifungal Agents / economics
  • Antifungal Agents / therapeutic use*
  • Candidiasis / drug therapy*
  • Candidiasis, Oral / drug therapy*
  • Drug Costs
  • Esophageal Diseases / drug therapy*
  • Fluconazole / economics
  • Fluconazole / therapeutic use
  • Humans
  • Ketoconazole / economics
  • Ketoconazole / therapeutic use
  • Medical Audit*
  • Practice Guidelines as Topic
  • Retrospective Studies

Substances

  • Antifungal Agents
  • Fluconazole
  • Ketoconazole